Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy

Journal of Cardiac Failure

Volumn 18, Issue 6, 2012, Pages 487-492

  Essa, Essa M ^a   Zile, Michael R ^b   Stroud, Robert E ^c   Rice, Allison ^c   Gumina, Richard J ^a   Leier, Carl V ^a   Spinale, Francis G ^d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; Metalloproteinases; stress; stress induced cardiomyopathy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERSTITIAL COLLAGENASE; MATRILYSIN; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HEART FAILURE; DYSPNEA; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TAKOTSUBO CARDIOMYOPATHY; THORAX PAIN;

CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TAKOTSUBO CARDIOMYOPATHY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84861634617     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.04.002     Document Type: Article

References (49)

1. K. Dote, H. Sato, H. Tateishi, T. Uchida, and M. Ishihara Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases J Cardiol 21 1991 203 214
2. S.W. Sharkey, J.R. Lesser, A.G. Zenovich, M.S. Maron, J. Lindberg, and T.F. Longe Acute and reversible cardiomyopathy provoked by stress in women from the United States Circulation 111 2005 472 479
3. K.A. Bybee, A. Prasad, G.W. Barsness, A. Lerman, A.S. Jaffe, and J.G. Murphy Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome Am J Cardiol 94 2004 343 346
4. G.W. Dec Recognition of the apical ballooning syndrome in the United States Circulation 111 2005 388 390
5. W.J. Desmet, B.F. Adriaenssens, and J.A. Dens Apical ballooning of the left ventricle: first series in white patients Heart 89 2003 1027 1031
6. D. Pavin, H. Le Breton, and C. Daubert Human stress cardiomyopathy mimicking acute myocardial syndrome Heart 78 1997 509 511
7. K.A. Bybee, T. Kara, A. Prasad, A. Lerman, G.W. Barsness, and R.S. Wright Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction Ann Intern Med 141 2004 858 865
8. A. Prasad, A. Lerman, and C.S. Rihal Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction Am Heart J 155 2008 408 417
9. K.A. Bybee, and A. Prasad Stress-related cardiomyopathy syndromes Circulation 118 2008 397 409
10. Y.J. Akashi, D.S. Goldstein, G. Barbaro, and T. Ueyama Takotsubo cardiomyopathy: a new form of acute, reversible heart failure Circulation 118 2008 2754 2762
11. I.S. Wittstein, D.R. Thiemann, J.A. Lima, K.L. Baughman, S.P. Schulman, and G. Gerstenblith Neurohumoral features of myocardial stunning due to sudden emotional stress N Engl J Med 352 2005 539 548
12. H.M. Nef, H. Möllmann, S. Kostin, C. Troidl, S. Voss, and M. Weber Tako-tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery Eur Heart J 28 2007 2456 2464
13. B. Ibanez, F. Navarro, M. Cordoba, P. M-Alberca, and J. Farre Tako-tsubo transient left ventricular apical ballooning: is intravascular ultrasound the key to resolve the enigma? Heart 91 2005 102 104
14. T. Scott-Burden Extracellular matrix: the cellular environment NiPS 9 1994 110 115
15. H. Nagase, R. Visse, and G. Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 2006 562 573
16. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
17. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
18. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
19. C.S. Webb, D.D. Bonnema, S.H. Ahmed, A.H. Leonardi, C.D. McClure, and L.L. Clark Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling Circulation 114 2006 1020 1027
20. P. Carmeliet Proteinases in cardiovascular aneurysms and rupture: targets for therapy? J Clin Invest 105 2000 1519 1520
21. Y. Nagatomo, B.A. Carabello, M.L. Coker, P.J. McDermott, S. Nemoto, and M. Hamawaki Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control Am J Physiol Heart Circ Physiol 278 2000 H151 H161
22. A.L. Chancey, G.L. Brower, J.T. Peterson, and J.S. Janicki Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload Circulation 105 2002 1983 1988
23. M.J. Cox, H.S. Sood, M.J. Hunt, D. Chandler, J.R. Henegar, and G.M. Aru Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats Am J Physiol Heart Circ Physiol 282 2002 H1197 H1205
24. H.E. Kim, S.S. Dalal, E. Young, M.J. Legato, and M.L. Weisfeldt d'Armiento J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 2000 857 866
25. J.D. Stroud, C.F. Baicu, M.A. Barnes, F.G. Spinale, and M.R. Zile Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment Am J Physiol Heart Circ Physiol 282 2002 H2324 H2335
26. F.G. Spinale Myocardial matrix remodeling and the matrix metalloproteinases: influence of cardiac form and function Physiol Rev 87 2007 1285 1342
27. M.R. Zile, S.M. Desantis, C.F. Baicu, R.E. Stroud, S.B. Thompson, and C.D. McClure Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure Circ Heart Fail 4 2011 246 256
28. M.L. Lindsey, D.K. Goshorn, C.E. Squires, G.P. Escobar, J.W. Hendrick, and J.T. Mingoia Age-dependent changes in myocardial matrix metalloproteinase/ tissue inhibitor of metalloproteinase profiles and fibroblast function Cardiovasc Res 66 2005 410 419
29. W.M. Yarbrough, R. Mukherjee, J.S. Ikonomidis, M.R. Zile, and F.G. Spinale Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications J Thorac Cardiovasc Surg 143 2012 656 664
30. M.H. Tayebjee, S.K. Nadar, R.J. MacFadyen, and G.Y. Lip Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension: relationship to tissue Doppler indices of diastolic relaxation Am J Hypertens 17 2004 770 774
31. M.H. Tayebjee, S. Nadar, and A.D. Blann Gareth Beevers D, MacFadyen RJ, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Am J Hypertens 17 2004 764 769
32. M.H. Tayebjee, H.S. Lim, S. Nadar, R.J. MacFadyen, and G.Y. Lip Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue Doppler in patients with type 2 diabetes and hypertension Eur J Clin Invest 35 2005 8 12
33. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
34. K. Alfakih, S. Plein, H. Thiele, T. Jones, J.P. Ridgway, and M.U. Sivananthan Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences J Magn Reson Imaging 17 2003 323 329
35. S.H. Ahmed, L.L. Clark, W.R. Pennington, C.S. Webb, D.D. Bonnema, and A.H. Leonardi Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease Circulation 113 2006 2089 2096
36. D.D. Bonnema, C.S. Webb, W.R. Pennington, R.E. Stroud, A.E. Leonardi, and L.L. Clark Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) J Card Fail 13 2007 530 540
37. A.A. Alsheikh-Ali, G.D. Kitsios, E.M. Balk, J. Lau, and S. Ip The vulnerable atherosclerotic plaque: scope of the literature Ann Intern Med 153 2010 387 395
38. J.P. Sluijter, W.P. Pulskens, A.H. Schoneveld, E. Velema, C.F. Strijder, and F. Moll Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms Stroke 37 2006 235 239
39. J. Wang, D. Xu, X. Wu, C. Zhou, H. Wang, and Y. Guo Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis Heart 97 2011 1542 1546
40. K. Gopcevic, B. Rovcanin, D. Kekic, and S. Radenkovic Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction Mol Cell Biochem 350 2011 163 168
41. R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, C. Conlon, and A. Patle Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction Circulation 115 2007 888 895
42. A. González, B. López, R. Querejeta, E. Zubillaga, T. Echeverría, and J. Díez Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction Hypertension 55 2010 1418 1424
43. C. Laviades, N. Varo, J. Fernández, G. Mayor, M.J. Gil, and I. Monreal Abnormalities of the extracellular degradation of collagen type I in essential hypertension Circulation 98 1998 535 540
44. W. Briest, A. Hölzl, B. Rassler, A. Deten, M. Leicht, and H.A. Baba Cardiac remodeling after long term norepinephrine treatment in rats Cardiovasc Res 52 2001 265 273
45. Y.T. Chiu, C.C. Cheng, N.N. Lin, Y.W. Hung, Y.T. Chen, and S.L. Hsu High-dose norepinephrine induces disruption of myocardial extracellular matrix and left ventricular dilatation and dysfunction in a novel feline model J Chin Med Assoc 69 2006 343 350
46. W. Barth, A. Deten, M. Bauer, M. Reinohs, M. Leicht, and H.G. Zimmer Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen J Mol Cell Cardiol 32 2000 273 284
47. S. Miura, I. Ohno, J. Suzuki, K. Suzuki, S. Okada, and A. Okuyama Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by beta-adrenergic stimulation in rats J Cardiovasc Pharmacol 42 2003 174 181
48. Y. Hori, S. Kunihiro, S. Sato, K. Yoshioka, Y. Hara, and K. Kanai Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats Biol Pharm Bull 32 2009 1678 1682
49. C. Banfi, V. Cavalca, F. Veglia, M. Brioschi, S. Barcella, and L. Mussoni Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure Eur Heart J 26 2005 481 488